KALA BIO, Inc.

Stage 4 · Declining · week 47

As of Oct 22, 2026, KALA BIO is in Stage 4, the downtrend phase, now in week 47 (since Nov 14, 2025). It closed at $0.19, 99.7% below its 52-week high and below its 200-day average, which is falling.

$0.19

-2.52% today

$3.6M · Micro cap

Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Steady

Edge

—

Is KALA early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2023-08-16 → 2026-10-22

S4 20w

S1 14w

S2 14w

S4 49w

2023-08-162026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S3 2w → S4 20w → S1 14w → S4 12w → S1 3w → S4 12w → S1 7w → S2 14w → S3 2w → S4 11w → S1 6w → S2 8w → S3 4w → S4 49w current

Total tracked: 165 weeks across 14 stage runs.

KALA among Biotechnology549th of 591 by relative strength

All 591 →

Stocks in Biotechnology ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	GTBPGT Biopharma, Inc.	Stage 2 · wk 7	99	−22.3%
2	IOVAIovance Biotherapeutics, Inc.	Stage 2 · wk 18	99	+38.8%
3	SLSSELLAS Life Sciences Group, Inc.	Stage 3 · wk 4	99	−1.5%
4	MRNAModerna, Inc.	Stage 2 · wk 17	99	+11.3%
5	TWSTTwist Bioscience Corporation	Stage 2 · wk 39	99	−14.5%
6	KODKodiak Sciences Inc	Stage 2 · wk 4	99	+172.1%
7	ERASErasca, Inc.	Stage 3 · wk 5	99	+0.7%
8	CLYMClimb Bio, Inc.	Stage 3 · wk 3	99	−15.8%
…549	KALAKALA BIO, Inc.	Stage 4 · wk 47	2	−66.8%

vs 52W High

-99.7%

$0.19 lo$66.50 hi

99.7% below 52W high, deep Stage 4 damage

In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.

Stage Maturity

Week 47

1w13w26w

Week 47, extended decline

How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.

vs 200 DMA

-97.6%

200 DMA: $7.75 · sloping down

In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.

Rel Volume

0.06x

vs 50-day avg

High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.

Trend Health

↓

Short-term trend rolling over

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

-66.8%

-70.7%

-97.6%

YTD

-99.4%

-99.6%

Scan Membership

Breakout Watch

Latest: 2024-12-26

5 appearances in last 60 days. First seen: 2020-02-06.

A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.

Recent Stage Timeline

2026-10-22S4

Wk 47 · Vol 0.06x

2026-10-21S4

Wk 47 · Vol 0.12x

2026-10-20S4

Wk 47 · Vol 0.20x

2026-10-19S4

Wk 47 · Vol 0.13x

2026-10-16S4

Wk 47 · Vol 0.15x

2026-10-15S4

Wk 46 · Vol 0.46x

2026-10-14S4

Wk 46 · Vol 0.91x

2026-10-13S4

Wk 46 · Vol 0.23x

2026-10-12S4

Wk 46 · Vol 0.21x

2026-10-09S4

Wk 46 · Vol 0.16x

2026-10-08S4

Wk 45 · Vol 0.36x

2026-10-07S4

Wk 45 · Vol 0.36x

Moving averages & range

50 DMA

$0.53

200 DMA

$7.75

52W High

$66.50

52W Low

$0.19

5D Low

$0.19

Resistance levels (recent highs)

20d High

$0.50

60d High

$0.95

120d High

$5.75

250d High

$66.50

Next resistance

+170.4%

to 20d High

ROE

-345.3%

Profit margin 0.0%

Dividend Yield

0.00%

P/B 0.4

KALA BIO: quick answers

What stage is KALA BIO in?

As of Oct 22, 2026, KALA BIO (KALA) is in Stage 4, the downtrend phase. It entered Stage 4 on Nov 14, 2025 and is in week 47. What the four stages mean

Is KALA BIO in an uptrend?

No. KALA BIO is in a Stage 4 downtrend. It trades 97.6% below its 200-day average, which is falling.

How far is KALA BIO from its 52-week high?

KALA BIO closed at $0.19 on Oct 22, 2026, 99.7% below its 52-week high of $66.50. Its 52-week low is $0.19.

How has KALA BIO performed over the past year?

As of Oct 22, 2026, KALA BIO is down 99.6% over the past year and down 99.4% so far in 2026.

Which sector and industry is KALA BIO in?

KALA BIO is in the Biotechnology industry, part of the Health Care sector.

About this companyHealth Care· Biotechnology

KALA BIO, Inc., a biopharmaceutical company, engages in the development of an on-premises artificial intelligence (AI) infrastructure platform for biotechnology research applications in the United States. The company develops Researgency, an agentic AI research platform for private enterprise AI deployment. Its platform intends to utilize the KPI-012 clinical development dataset as a proof-of-concept validation environment, as well as the mesenchymal stem cell secretome (MSC-S) and persistent corneal epithelial defects (PCED) research for agentic workflows on trial data. The company serves biotechnology and pharmaceutical companies. The company was formerly known as Kala Pharmaceuticals, Inc. and changed its name to KALA BIO, Inc. in August 2023. KALA BIO, Inc. was incorporated in 2009 and is headquartered in Arlington, Massachusetts.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.